Emvision Medical Devices Ltd Asset Resilience Ratio
Emvision Medical Devices Ltd asset resilience ratio. Emvision Medical Devices Ltd (EMV) has an Asset Resilience Ratio of 0.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Emvision Medical Devices Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Emvision Medical Devices Ltd (2022–2025)
Asset resilience ratio of Emvision Medical Devices Ltd from 2022 to 2025. This chart shows how Emvision Medical Devices Ltd's Asset Resilience Ratio has changed over time. Read EMV total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Emvision Medical Devices Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EMV total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$14.59K | 0.06% |
| Total Liquid Assets | AU$14.59K | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Emvision Medical Devices Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Emvision Medical Devices Ltd Industry Peers by Asset Resilience Ratio
Compare Emvision Medical Devices Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Emvision Medical Devices Ltd Asset Resilience Ratio by Year (2022–2025)
Emvision Medical Devices Ltd asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for Emvision Medical Devices Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.47% | AU$73.65K ≈ $52.11K |
AU$15.57 Million ≈ $11.02 Million |
+0.18pp |
| 2024-06-30 | 0.30% | AU$70.94K ≈ $50.20K |
AU$23.97 Million ≈ $16.96 Million |
-2.38pp |
| 2023-06-30 | 2.68% | AU$308.44K ≈ $218.24K |
AU$11.52 Million ≈ $8.15 Million |
+0.62pp |
| 2022-06-30 | 2.06% | AU$175.12K ≈ $123.91K |
AU$8.51 Million ≈ $6.02 Million |
-- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more